Related Experiment Video
Updated: May 12, 2026
07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
13.9K
PEGylation Effects on Amphiphilic Platinum(IV) Complexes: Influence on Uptake, Activation, and Cytotoxicity
Arpit Sharma1, Md Al Amin1, Man B Kshetri1
1Department of Chemistry and Biochemistry, Kent State University, 236 Integrated Sciences Building, Kent, OH 44242, USA.
Pharmaceutics
|April 26, 2025
Summary
PEGylation of platinum(IV) (Pt(IV)) complexes impacts cancer therapy. Small PEG chains enhance efficacy, while large chains hinder cellular uptake and activation, reducing anticancer activity.
Area of Science:
- Medicinal Chemistry
- Nanotechnology
- Cancer Therapy
Background:
- Amphiphilic platinum(IV) (Pt(IV)) complexes are promising prodrugs for cancer therapy.
- PEGylation is a common strategy to improve drug properties, but its effect on Pt(IV) complexes is not well understood.
Purpose of the Study:
- To investigate how varying PEGylation molecular weights affect the biological behavior of amphiphilic Pt(IV) prodrugs.
- To understand the influence of PEGylation on cytotoxicity, cellular uptake, and activation mechanisms.
Main Methods:
- Synthesis of Pt(IV) complexes with different PEG chain lengths via amide bond formation and click chemistry.
- Assessment of biological properties including cytotoxicity, cellular uptake, and activation by biological reductants.
Main Results:
- Small PEG modifications maintained potent cytotoxicity.
- Large PEG chains significantly reduced efficacy due to impaired cellular uptake and mitochondrial accumulation.
- Large PEG chains also slowed Pt(IV) prodrug reduction and activation, limiting anticancer activity.
Conclusions:
- PEGylation plays a critical role in the design of metallodrugs.
- Optimizing PEGylation strategies is essential for enhancing platinum-based cancer therapies.
Related Concept Videos
01:19Complexation Equilibria: The Chelate Effect
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
01:22EDTA: Chemistry and Properties
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...